GSK-3β controls NF-kappaB activity via IKKγ/NEMO

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• The NF-κB pathway is vital for innate immunity and its dysregulation contributes to various diseases.
• IKKγ/NEMO is essential for NF-κB activation; NEMO dysfunction is linked to progeria syndromes.
• The role of glycogen synthase kinase-3β (GSK-3β) in NF-κB regulation was not fully understood.

Purpose of the Study:

• To elucidate the mechanism by which GSK-3β regulates the NF-κB signaling pathway.
• To identify and characterize the interaction between GSK-3β and NEMO.

Main Methods:

• Phosphorylation site mapping of NEMO by GSK-3β.
• Analysis of GSK-3β-NEMO complex formation using wild-type and mutated NEMO.
• Assessment of NEMO stability, ubiquitination, and NF-κB activation upon TNFα stimulation.

Main Results:

• NEMO was identified as a GSK-3β substrate, phosphorylated at specific N-terminal serine residues (8, 17, 31, 43).
• Mutations at these serine sites disrupted GSK-3β binding and NEMO phosphorylation, leading to NEMO destabilization.
• Mutated NEMO showed increased K63-linked polyubiquitination and IκBα degradation, but impaired TNFα-stimulated NF-κB activation.

Conclusions:

• GSK-3β plays a critical role in the ordered activation of the NF-κB signaling pathway.
• NEMO phosphorylation by GSK-3β is essential for maintaining controlled NF-κB signaling and preventing aberrant immune responses.